These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 21115895

  • 1. Sequential X-irradiation induced acquired resistance to oxaliplatin but increased sensitivity to cisplatin in two human teratoma cell lines in vitro.
    Eisenmann S, Voigt W, Müller T, Dempke W.
    Anticancer Res; 2010 Nov; 30(11):4471-6. PubMed ID: 21115895
    [Abstract] [Full Text] [Related]

  • 2. Resistance mechanisms following cisplatin and oxaliplatin treatment of the human teratocarcinoma cell line 2102EP.
    Rennicke A, Voigt W, Mueller T, Fruehauf A, Schmoll HJ, Beyer C, Dempke W.
    Anticancer Res; 2005 Nov; 25(2A):1147-55. PubMed ID: 15868958
    [Abstract] [Full Text] [Related]

  • 3. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
    Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810
    [Abstract] [Full Text] [Related]

  • 4. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 5. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
    Toyozumi Y, Arima N, Izumaru S, Kato S, Morimatsu M, Nakashima T.
    Int J Oncol; 2004 Sep 15; 25(3):721-8. PubMed ID: 15289875
    [Abstract] [Full Text] [Related]

  • 6. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A, Horváth V, Svihálková-Sindlerová L, Soucek K, Hofmanová J, Sova P, Kroutil A, Zák F, Mistr A, Turánek J.
    Biochem Pharmacol; 2005 Feb 01; 69(3):373-83. PubMed ID: 15652229
    [Abstract] [Full Text] [Related]

  • 7. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
    Perry J, Powles T, Shamash J, Veerupillai A, McGrowder E, Noel E, Lu YJ, Oliver T, Joel S.
    Cancer Chemother Pharmacol; 2009 Oct 01; 64(5):925-33. PubMed ID: 19263053
    [Abstract] [Full Text] [Related]

  • 8. Expression of proteins correlated with the unique cisplatin-sensitivity of testicular cancer.
    de Graaf TW, de Jong S, de Vries EG, Mulder NH.
    Anticancer Res; 1997 Oct 01; 17(1A):369-75. PubMed ID: 9066679
    [Abstract] [Full Text] [Related]

  • 9. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K, Oshima T, Kobayashi T, Yamamoto N, Hayashi C, Matsumoto T, Miwa H.
    Anticancer Res; 2008 Oct 01; 28(4B):2087-92. PubMed ID: 18751380
    [Abstract] [Full Text] [Related]

  • 10. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R, Krausz E, Ruotsalainen P, Helenius H, Hietanen S.
    Cancer Res; 2002 Dec 15; 62(24):7364-71. PubMed ID: 12499281
    [Abstract] [Full Text] [Related]

  • 11. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC, de Vries EG, Vellenga E, de Jong S.
    Cell Death Differ; 2003 Jul 15; 10(7):808-22. PubMed ID: 12815464
    [Abstract] [Full Text] [Related]

  • 12. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
    Horváth V, Blanárová O, Svihálková-Sindlerová L, Soucek K, Hofmanová J, Sova P, Kroutil A, Fedorocko P, Kozubík A.
    Gynecol Oncol; 2006 Jul 15; 102(1):32-40. PubMed ID: 16364413
    [Abstract] [Full Text] [Related]

  • 13. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
    Ekblad L, Kjellström J, Johnsson A.
    Anticancer Drugs; 2010 Jun 15; 21(5):523-31. PubMed ID: 20168208
    [Abstract] [Full Text] [Related]

  • 14. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF, Koberle B, Masters JR, Kelland LR.
    Br J Cancer; 1999 Dec 15; 81(8):1294-303. PubMed ID: 10604725
    [Abstract] [Full Text] [Related]

  • 15. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K, Takemura K, Kihara M, Naito S, Lee E, Shimizu E, Yamauchi A.
    Oncol Rep; 2005 Jun 15; 13(6):1229-34. PubMed ID: 15870947
    [Abstract] [Full Text] [Related]

  • 16. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.
    Watanabe J, Nishiyama H, Matsui Y, Ito M, Kawanishi H, Kamoto T, Ogawa O.
    Oncogene; 2006 Apr 20; 25(17):2500-8. PubMed ID: 16518417
    [Abstract] [Full Text] [Related]

  • 17. Clonal variability of radiation-induced cisplatin resistant HeLa cells.
    Eichholtz-Wirth H, Marx K.
    Anticancer Res; 1998 Apr 20; 18(4C):2989-91. PubMed ID: 9713497
    [Abstract] [Full Text] [Related]

  • 18. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
    Hrstka R, Powell DJ, Kvardova V, Roubalova E, Bourougaa K, Candeias MM, Sova P, Zak F, Fåhraeus R, Vojtĕsek B.
    Anticancer Drugs; 2008 Apr 20; 19(4):369-79. PubMed ID: 18454047
    [Abstract] [Full Text] [Related]

  • 19. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK, Davey MW, Davey RA.
    Cancer Chemother Pharmacol; 2006 Aug 20; 58(2):256-65. PubMed ID: 16283310
    [Abstract] [Full Text] [Related]

  • 20. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK, Schadendorf D, Röckmann H.
    Melanoma Res; 2006 Dec 20; 16(6):527-35. PubMed ID: 17119454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.